View in EDS HTML Full Text PDF Full Text

Unexpectedly long persistence of anti‐SARS‐CoV‐2 spike monoclonal antibodies tixagevimab and cilgavimab in immunocompromised patients.

Saved in:
Bibliographic Details
Title: Unexpectedly long persistence of anti‐SARS‐CoV‐2 spike monoclonal antibodies tixagevimab and cilgavimab in immunocompromised patients.
Authors: Perrier, Quentin1 (AUTHOR), Lupo, Julien2 (AUTHOR), Epaulard, Olivier3 (AUTHOR) OEpaulard@chu-grenoble.fr
Source: Transplant Infectious Disease. Dec2023, Vol. 25 Issue 6, p1-3. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13982273
DOI:10.1111/tid.14164